Ring Opening of 1,5-Dioxaspiro[3.2]hexanes: Selective Preparation of α-Heterofunctionalized-β‘-hydroxy Ketones or 2,2-Disubstituted Oxetanes
摘要:
[GRAPHICS]2-Methyleneoxetanes have been converted into 1,5 dioxaspiro[3.2]hexanes with dimethyldioxirane. Reaction of the dioxaspirohexanes with a range of heteroatom nucleophiles, hydride donors, or organoaluminum reagents was successful under neutral or mild conditions, affording, selectively, polyfunctionalized ketones or 2,2 disubstituted oxetanes.
Directed Ring-Opening of 1,5-Dioxaspiro[3.2]hexanes: Selective Formation of 2,2-Disubstituted Oxetanes
作者:Rosa Taboada、Grace G. Ordonio、Albert J. Ndakala、Amy R. Howell、Paul R. Rablen
DOI:10.1021/jo0206465
日期:2003.2.1
nucleophiles provide 2,2-disubstituted oxetanes. Herein, the results of reactions of 3-phenyl-1,5-dioxaspiro[3.2]hexane with a variety of nitrogen-containing heteroaromatic bases are reported. There appears to be a correlation between the pK(a) of the nucleophile and the reaction outcome with more acidic nucleophiles providing 2,2-disubstituted oxetanes. Moreover, the mode of ring opening can be directed toward
[EN] HETEROCYCLYL-SUBSTITUTED OXETANES FOR THE TREATMENT OF PROLIFERATIVE OR INFECTIOUS DISEASES<br/>[FR] OXETANES A SUBSTITUTION HETEROCYCLYLE PERMETTANT DE TRAITER DES MALADIES PROLIFERATIVES OU INFECTIEUSES
申请人:UNIV CONNECTICUT
公开号:WO2005051944A1
公开(公告)日:2005-06-09
Oxetane-containing nucleosides, particularly non-reducing psiconucleoside oxetanes (1) are described herein. Therapeutic application of these oxetane compounds toward the treatment of nucleoside analog related disorders such as disorders involving cellular proliferation and infection are also described.
Substituted oxetanes, method of making, and method of use thereof
申请人:Howell R. Amy
公开号:US20050215568A1
公开(公告)日:2005-09-29
Oxetane-containing nucleosides, particularly non-reducing psiconucleoside oxetanes are described herein. Therapeutic application of these oxetane compounds toward the treatment of nucleoside analog related disorders such as disorders involving cellular proliferation and infection are also described.
SUBSTITUTED OXETANES, METHOD OF MAKING, AND METHOD OF USE THEREOF
申请人:Howell Amy R.
公开号:US20080139566A1
公开(公告)日:2008-06-12
Oxetane-containing nucleosides, particularly non-reducing psiconucleoside oxetanes are described herein. Therapeutic application of these oxetane compounds toward the treatment of nucleoside analog related disorders such as disorders involving cellular proliferation and infection are also described.
Synthesis of <i>epi</i>-Oxetin via a Serine-Derived 2-Methyleneoxetane
作者:Marisa L. Blauvelt、Amy R. Howell
DOI:10.1021/jo7018762
日期:2008.1.1
[GRAPHICS]The unique reactivity of 2-methyleneoxetanes and 1,5-dioxaspiro[3.2]hexanes has been exploited for the synthesis of epi-oxetin (26), an oxetane-containing beta-amino acid. While the preparation of the natural product oxetin (1) was the original goal, the unexpected diastereoselectivity of an precedented reduction provided the epi-oxetin framework. The methodology described herein should be amenable for the preparation of oxetin with a change in nitrogen protection.